← Every company
CRISPR Therapeutics AG Planned Sales
Before an insider at CRISPR Therapeutics AG can sell restricted stock they have to file notice of it. This is that notice — the leading edge of the insider trading feed, filed days before the sale it describes.
CRSP insider trades →Notices on file
3
Insiders
2
Shares noticed
26.1K
permission to sell, not sales
Estimated value
$1.5M
as estimated on filing
Largest notices first
Value is the filer's own estimate of what the sale would raise, at the time they filed.
| Seller | Est. value |
|---|---|
| Behbahani AliDirector2026-09-1713.7K sh0.01% | $780.9K |
| Kasinger JamesOfficer2026-09-2210.4K sh0.01% | $626.5K |
| Kasinger JamesOfficer2026-10-062K sh<0.01% | $119.5K |
Source: SEC Form 144 notices, via EDGAR. A notice is permission to sell, not a completed sale — it is often used only in part, or not at all, so none of this is volume and none of it should be added to the insider trading feed. Value is the filer's estimate on the day they filed.
More on CRSP
Company overviewEverything on CRSP in one place, with the price.SEC filingsWhat CRSP's 8-Ks say happened: results, departures, auditor changes.Insider tradingWhat CRSP's own officers and directors buy and sell.Executive payWhat CRSP awarded its chief executive, and what it became.LobbyingWhat CRSP spends lobbying Congress, and on what.PatentsWhat CRSP is filing at the patent office.